Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs

References

• Ajzen , I. and Fishbein , M. 1975 . Belief, attitude, intention and behavior: An introduction to Theory and Research , Reading , MA : Addison-Wesley .
   Google Scholar
• Ajzen , I. and Fishbein , M. 1980 . Understanding attitudes and predicting social behavior , Englewood Cliffs , NJ : Prentice-Hall .
   Google Scholar
• Back , D.J. , Blaschke , T. , Boucher , C. , Burger , D. , Fletcher , C. , Flexner , C. et al. . 2003 . OptimizingTDM in HIV clinical care: A practical guide to performing therapeutic drugmonitoring(TDM) for antiretroviral agents . Version 1.0. Available at: http://www.hivpharmacology.com/ .
   Google Scholar
• Bangsberg , D.R. 2006 . Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression . Clinical Infectious Diseases , 43 : 939 – 941 .
   PubMed Web of Science ®Google Scholar
• Beach , M.C. , Keruly , J. and Moore , R.D. 2006 . Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? . Journal of General Internal Medicine , 21 : 661 – 665 .
   PubMed Web of Science ®Google Scholar
• Becker , M.H. 1974 . The Health Belief Model and Personal Health Behavior . Health Education Monographs , 2 : 354 – 386 .
   Google Scholar
• Braitstein , P. , Justice , A. , Bangsberg , D.R. , Yip , B. , Alfonso , V. Schechter , M.T. 2006 . Hepatitis C-co-infection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort . AIDS , 20 : 323 – 331 .
   PubMed Web of Science ®Google Scholar
• Carrieri , M.P. , Raffi , F. , Lewden , C. , Sobel , A. , Michelet , C. Cailleton , V. 2003 . Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: A 3-year follow-up study . Antiviral Therapy , 8 : 585 – 594 .
   PubMed Web of Science ®Google Scholar
• Fumaz , C.R. , Munoz-Moreno , J.A. , Molto , J. , Negredo , E. , Ferrer , M.J. Sirera , G. 2005 . Long-term neuropsychiatric disorders on efavirenz-based approaches: Quality of life, psychologic issues and adherence . Journal of Acquired Immune Deficiency Syndromes , 38 : 560 – 565 .
   PubMed Web of Science ®Google Scholar
• Glass , T.R. , De Geest , S. , Weber , R. , Vernazza , P.L. , Rickenbach , M. Furrer , H. 2006 . Correlates of self-reported non-adherence to antiretroviral therapy in HIV-infected patients: The Swiss HIV Cohort Study . Journal Of Acquired Immune Deficiency Syndromes , 41 : 385 – 392 .
   PubMed Web of Science ®Google Scholar
• Gonza′ lez de Requena , D. , Bonora , S. , Canta , F. , Marrone , R. , D'Avolio , A. , Sciandra , M. et al. 2005 . Atazanavir Ctrough is associated with efficacy and safety: Definition of therapeutic range [abstract 645] . Presented at the 12th Conference on Retroviruses and Opportunistic Infections; Boston, USA .
   Google Scholar
• Halkitis , P.N. , Kutnick , A.H. and Slater , S. 2005 . The social realities of adherence to protease inhibitor regimens: Substance use, healthcare and psychological states . Journal of Health Psychology , 10 : 545 – 558 .
   PubMed Web of Science ®Google Scholar
• Halkitis , P.N. , Kutnick , A.H. and Slater , S. 2005 . The social realities of adherence to protease inhibitor regimens: Substance use, healthcare and psychological states . Journal of Health Psychology , 10 : 545 – 558 .
   PubMed Web of Science ®Google Scholar
• Hammer , S.M. , Saag , M.S. , Schechter , M. , Montaner , J.S. , Schooley , R.T. Jacobsen , D.M. 2006 . Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel . Journal of the American Medical Association , 296 : 827 – 843 .
   PubMed Web of Science ®Google Scholar
• Ironson , G. , O'Cleirigh , C. , Fletcher , M.A. , Laurenceau , J.P. , Balbin , E. Klimas , N. 2005 . Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment . Psychosomatic Medicine , 67 : 1013 – 1021 .
   PubMed Web of Science ®Google Scholar
• Locadia , M. , van Grieken , R.A. , Prins , J.M. , de Vries , H.J. , Sprangers , M.A. and Nieuwkerk , P.T. 2006 . Patients’ preferences regarding the timing of highly active antiretroviral therapy initiation for chronic asymptomatic HIV-1 infection . Antiviral Therapy , 11 : 335 – 341 .
   PubMed Web of Science ®Google Scholar
• Lucas , G.M. , Wu , A.W. and Cheever , L.W. 2004 . Adherence to antiretroviral therapy: An update of current concepts . Current HIV/AIDS Reports , 1 : 172 – 180 .
   PubMedGoogle Scholar
• Molassiotis , A. , Nahas-Lopez , V. , Chung , W.Y. , Lam , S.W. , Li , C.K. and Lau , T.F. 2002 . Factors associated with adherence to antiretroviral medication in HIV-infected patients . International Journal of STD & AIDS , 13 : 301 – 310 .
   PubMed Web of Science ®Google Scholar
• Molto , J. , Blanco , A. , Miranda , C. , Miranda , J. , Puig , J. Valle , M. 2006 . Variability in non-nucleoside reverse transcriptase and protease inhibitor concentrations among HIV-infected adults in routine clinical practice . British Journal of Clinical Pharmacology , 62 : 560 – 566 .
   PubMed Web of Science ®Google Scholar
• Moyle , G.J. and Gazzard , B.G. 1999 . A risk-benefit assessment of HIV protease inhibitors . Drug Safety , 20 : 299 – 321 .
   PubMed Web of Science ®Google Scholar
• Murri , R. , Ammassari , A. , Gallicano , K. , De Luca , A. , Cingolani , A. Jacobson , D. 2000 . Patient-reported nonadherence to HAART is related to protease inhibitor levels . Journal of Acquired Immune Deficiency Syndromes , 24 : 123 – 128 .
   PubMed Web of Science ®Google Scholar
• Negredo , E. , Molto , J. , Munoz-Moreno , J.A. , Pedrol , E. , Ribera , E. Viciana , P. 2004 . Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach . Antiviral Therapy , 9 : 335 – 342 .
   PubMed Web of Science ®Google Scholar
• Nettles , R.E. , Kieffer , T.L. , Parsons , T. , Johnson , J. , Cofrancesco , J. Jr Gallant , J.E. 2006 . Marked intra-individual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring . Clinical Infectious Diseases , 42 : 1189 – 1196 .
   PubMed Web of Science ®Google Scholar
• Paterson , D.L. , Swindells , S. , Mohr , J. , Brester , M. , Vergis , E.N. Squier , C. 2000 . Adherence to protease inhibitor therapy and outcomes in patients with HIV infection . Annals of Internal Medicine , 133 : 21 – 30 .
   PubMed Web of Science ®Google Scholar
• Portsmouth , S.D. , Osorio , J. , McCormick , K. , Gazzard , B.G. and Moyle , G.J. 2005 . Better maintained adherence on switching from twice-daily to once-daily therapy for HIV: A 24-week randomized trial of treatment simplification using stavudine prolonged-release capsules . HIV Medicine , 6 : 185 – 190 .
   PubMed Web of Science ®Google Scholar
• Rosenstock , I.M. 1974 . Historical origins of the Health Belief Model . Health Education Monographs , 2 : 328 – 335 .
   Google Scholar
• Ruiz , L. , Paredes , R. , Gómez , G. , Romeu , J. , Domingo , P. Pérez-Alvarez , N. 2007 . Antiretroviral therapy interruption guided by CD4+ counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients . AIDS , 21 : 169 – 178 .
   PubMed Web of Science ®Google Scholar
• Schultz , J.R. , Butler , R.B. , McKernan , L. , & Boelsen , R. & Haemophilia Behavioral Intervention Evaluation Project 2001 . Developing theory-based risk-reduction interventions for HIV-positive young people with haemophilia . Haemophilia , 7 , 64 – 71 .
   PubMed Web of Science ®Google Scholar
• Shuter , J. , Sarlo , J.A. , Kanmaz , T.J. , Rode , R.A. , & Zingman , B.S. 2006 . The ‘95% adherence rule’ may not apply to lopinavir/ritonavir (LPV/r) based HAART regimens [abstract TUPE0110] . Presented at the XVI International AIDS Conference; 2006; Toronto, Canada .
   Google Scholar
• Swindells , S. , DiRienzo , A.G. , Wilkin , T. , Fletcher , C.V. , Margolis , D.M. Thal , G.D. 2006 . Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression . Journal of the American Medical Association , 296 : 806 – 814 .
   PubMed Web of Science ®Google Scholar
• Tuldrà , A. , Fumaz , C.R. , Ferrer , M.J. , Bayés , R. , Arnó , A. Balagué , M. 2000 . Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy . Journal of Acquired Inmune Deficiency Syndromes , 25 : 221 – 228 .
   PubMed Web of Science ®Google Scholar
• van Servellen , G. , Chang , B. , Garcia , L. and Lombardi , E. 2002 . Individual and system level factors associated with treatment non-adherence in human immunodeficiency virus-infected men and women . AIDS Patient Care STDS , 16 : 269 – 281 .
   PubMed Web of Science ®Google Scholar
• Zak-Place , J. and Stern , M. 2004 . Health belief factors and dispositional optimism as predictors of STD and HIV preventive behavior . Journal of American College Health , 52 : 229 – 236 .
   PubMed Web of Science ®Google Scholar